Patent rights jointly owned by the National Cancer Center and the University of Pennsylvania, licensed to ARC Therapies, Inc.
Initiation of cell therapy research and development program for adult T-Cell leukemia / lymphoma (ATLL)
TOKYO, July 11, 2024 /PRNewswire/ — The National Cancer Center (Tokyo, Japan) and The University of Pennsylvania (Philade… อ่านเพิ่ม